HCV E2 Antikörper (AA 384-665)

Produktnummer ABIN264627

Der Ziege Polyklonal anti-HCV E2 Antikörper (ABIN264627) detektiert spezifisch HCV E2 in WB, IF und EIA. Dieser Antikörper reagiert spezifisch mit Proben aus Hepatitis C Virus (HCV).

Kurzübersicht für HCV E2 Antikörper (AA 384-665) (ABIN264627)

Target: HCV E2 (Hepatitis C Virus Envelope Protein E2 (HCV E2))

Reaktivität: Hepatitis C Virus (HCV)

Wirt: Ziege

Klonalität: Polyklonal

Konjugat: Dieser HCV E2 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunofluorescence (IF), Enzyme Immunoassay (EIA)

Produktdetails anti-HCV E2 Antikörper

Bindungsspezifität: AA 384-665

Aufreinigung: Sodium Sulfate Precipitation and Ion-Exchange Chromatography.

Immunogen: Recombinant E2 (genotype 1a)

Anwendungsinformationen

Applikationshinweise: Conjugation-ELISA. Western Blot.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 4-5 mg/mL (OD280nm, E0.1% = 1.4)

Buffer: 0.01 M PBS, pH 7.2 containing 0.09 % Sodium Azide as preservative and no stabilizing proteins.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Avoid repeated freezing and thawing.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Details zu HCV E2

Target: HCV E2 (Hepatitis C Virus Envelope Protein E2 (HCV E2))

Andere Bezeichnung: HCV Envelope Glycoprotein E2

Substanzklasse: Viral Protein

Hintergrund: Hepatitis C E2 is a virus envelope glycoprotein which forms a heterodimer with the E1 protein. E2 inhibits human EIF2AK2/PKR activation, preventing the establishment of an antiviral state. E2 is a viral ligand for CD209/DC-SIGN and CLEC4M/DC-SIGNR, which are respectively found on dendritic cells (DCs), and on liver sinusoidal endothelial cells and macrophage-like cells of lymph node sinuses. These interactions allow capture of circulating HCV particles by these cells and subsequent transmission to permissive cells. DCs are professional antigen presenting cells, critical for host immunity by inducing specific immune responses against a broad variety of pathogens. They act as sentinels in various tissues where they entrap pathogens and convey them to local lymphoid tissue or lymph node for establishment of immunity. Capture of circulating HCV particles by these SIGN+ cells may facilitate virus infection of proximal hepatocytes and lymphocyte subpopulations and may be essential for the establishment of persistent infection.Synonyms: Hepatitis C Virus NS1, gp68, gp70